Related Experiment Videos
Bronchial CD8 cell infiltrate and lung function decline in asthma.
Elizabeth L J van Rensen1, Jacob K Sont, Christine E Evertse
1Department of Pulmonology, C3-P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
American Journal of Respiratory and Critical Care Medicine
|August 9, 2005
Summary
Bronchial CD8+ T cell counts predict lung function decline in asthma patients, indicating inflammation
Area of Science:
- Pulmonary Medicine
- Immunology
- Respiratory Research
Background:
- Asthma patients experience accelerated lung function decline, potentially leading to irreversible airway obstruction.
- This decline is often attributed to specific airway inflammation and remodeling processes.
Purpose of the Study:
- To assess the prognostic value of bronchial eosinophil and CD8+ T cell counts, and subepithelial reticular layer thickness.
- To correlate these factors with lung function decline over 7.5 years in asthma patients.
Main Methods:
- Prospective study of 32 asthma patients measuring lung function (FEV1) over 7.5 years.
- Analysis of bronchial biopsies at baseline and Year 2 for inflammation and remodeling markers.
- Correlation of biopsy findings with annual lung function decline (pre- and post-bronchodilator FEV1).
Main Results:
- Annual decline in post-bronchodilator FEV1 was greater than pre-bronchodilator FEV1, suggesting loss of reversibility.
- No significant correlation found between lung function decline and reticular layer thickness or eosinophil counts.
- A significant inverse correlation was observed between CD8+ T cell counts and annual decline in post-bronchodilator FEV1, confirmed at Year 2.
Conclusions:
- Bronchial CD8+ T cell infiltration is a significant predictor of asthma outcome, specifically FEV1 decline.
- The inflammatory phenotype in asthma holds prognostic relevance.
- Findings suggest the need for phenotype-specific therapeutic strategies in asthma management.